Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Fouka, S. Anevlavis, K. Kaltsas, A. Antoniadis, D. Bouros (Thessaloniki, Alexandroupolis, Serres, Greece). Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients. Eur Respir J 2014; 44: Suppl. 58, 2541

Member's Comments

No comment yet.

Related content which might interest you: The use of home intravenous antibiotics in adult non-CF bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Influence of inhaled glucocorticosteroids on course of the bronchiectasis Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Effect of nintedanib on cough and health related quality of life in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Assessment of quality of life in patients with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Systematic review of the validity of health related quality of life (HRQOL) questionnaires in non-cystic fibrosis bronchiectasis (NCFB) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Effect of long term azithromycin on exacerbations in non CF bronchiectasis Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 34: 125-131 Year: 2009 The association between objective CT measures of bronchiectasis and health-related quality of life in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Quality of life in obstructive lung diseases Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Effect of roflumilast on quality of life in frequent and infrequent exacerbators Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 A randomised comparison of two tobramycin formulations in cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) infection for pharmacokinetic and therapeutic equivalence Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 The frequency of exacerbations in COPD patients and its influence on the effects of pulmonary rehabilitation Source: International Congress 2014 – Latest insights in chronic care Year: 2014